Dermatological lines for the treatment of intolerant skin

A careful analysis of customers’ needs enables OFI to develop and contract manufacture cosmetic lines for the targeted dermatological treatment of intolerant skin.

The cutaneous hydrolipid film, if partially developed or damaged by external aggression, causes the skin to become partially impermeable; it also causes changes to the microcirculation, reduces intracellular exchange and cell turn-over and induces inflammation at a dermal level. Specifically targeted dermatological treatments focus on eliminating pro-inflammatory factors and increasing the skin’s natural defences by preventing inflammation and protecting against free radicals which induce a self-perpetuating chain reaction of oxidative and cell degradation processes.